NDC 65649-303

XIFAXAN

Rifaximin

XIFAXAN is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Salix Pharmaceuticals, Inc.. The primary component is Rifaximin.

• Product ID: 65649-303_28ea5bf4-caab-4042-8272-62d7f1d62f48
• NDC: 65649-303
• Product Type: Human Prescription Drug
• Proprietary Name: XIFAXAN
• Generic Name: Rifaximin
• Dosage Form: Tablet
• Route of Administration: ORAL
• Marketing Start Date: 2010-05-01
• Marketing Category: NDA / NDA
• Application Number: NDA021361
• Labeler Name: Salix Pharmaceuticals, Inc.
• Substance Name: RIFAXIMIN
• Active Ingredient Strength: 550 mg/1
• Pharm Classes: Rifamycin Antibacterial [EPC],Rifamycins [CS]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 65649-303-01

3 CARTON in 1 TRAY (65649-303-01) > 1 BLISTER PACK in 1 CARTON > 2 TABLET in 1 BLISTER PACK

• Marketing Start Date: 2010-05-01
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 65649-303-03 [65649030303]

XIFAXAN TABLET

• Marketing Category: NDA
• Application Number: NDA021361
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2010-05-01

NDC 65649-303-02 [65649030302]

XIFAXAN TABLET

• Marketing Category: NDA
• Application Number: NDA021361
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2010-05-01

NDC 65649-303-04 [65649030304]

XIFAXAN TABLET

• Marketing Category: NDA
• Application Number: NDA021361
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2010-05-01
• Marketing End Date: 2020-04-30

NDC 65649-303-01 [65649030301]

XIFAXAN TABLET

• Marketing Category: NDA
• Application Number: NDA021361
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2010-05-01

NDC 65649-303-05 [65649030305]

XIFAXAN TABLET

• Marketing Category: NDA
• Application Number: NDA021361
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2010-05-01

Drug Details

Active Ingredients

Ingredient	Strength
RIFAXIMIN	550 mg/1

OpenFDA Data

• SPL SET ID: c5e8e2fd-7087-4b78-9181-cc259c0be2f1
• Manufacturer:
  • Salix Pharmaceuticals, Inc.
• UNII:
  • L36O5T016N
• RxNorm Concept Unique ID - RxCUI:
  • 856664
  • 856666
  • 429662
  • 539789
• UPC Code:
  • 0365649301032

Pharmacological Class

• Rifamycin Antibacterial [EPC]
• Rifamycins [CS]

Medicade Reported Pricing

65649030304 XIFAXAN 550 MG TABLET

Pricing Unit: EA | Drug Type:

65649030303 XIFAXAN 550 MG TABLET

Pricing Unit: EA | Drug Type:

65649030302 XIFAXAN 550 MG TABLET

Pricing Unit: EA | Drug Type:

NDC Crossover Matching brand name "XIFAXAN" or generic name "Rifaximin"

NDC	Brand Name	Generic Name
50090-2445	XIFAXAN	rifaximin
55154-6777	XIFAXAN	rifaximin
65649-301	XIFAXAN	rifaximin
65649-303	XIFAXAN	rifaximin
68151-4980	XIFAXAN	rifaximin
68258-1107	XIFAXAN	RIFAXIMIN
69189-0309	XIFAXAN	rifaximin